Literature DB >> 18424752

CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.

Masahide Takedachi1, Dongfeng Qu, Yukihiko Ebisuno, Hiroyuki Oohara, Michelle L Joachims, Stephanie T McGee, Emiko Maeda, Rodger P McEver, Toshiyuki Tanaka, Masayuki Miyasaka, Shinya Murakami, Thomas Krahn, Michael R Blackburn, Linda F Thompson.   

Abstract

After an inflammatory stimulus, lymphocyte migration into draining lymph nodes increases dramatically to facilitate the encounter of naive T cells with Ag-loaded dendritic cells. In this study, we show that CD73 (ecto-5'-nucleotidase) plays an important role in regulating this process. CD73 produces adenosine from AMP and is expressed on high endothelial venules (HEV) and subsets of lymphocytes. Cd73(-/-) mice have normal sized lymphoid organs in the steady state, but approximately 1.5-fold larger draining lymph nodes and 2.5-fold increased rates of L-selectin-dependent lymphocyte migration from the blood through HEV compared with wild-type mice 24 h after LPS administration. Migration rates of cd73(+/+) and cd73(-/-) lymphocytes into lymph nodes of wild-type mice are equal, suggesting that it is CD73 on HEV that regulates lymphocyte migration into draining lymph nodes. The A(2B) receptor is a likely target of CD73-generated adenosine, because it is the only adenosine receptor expressed on the HEV-like cell line KOP2.16 and it is up-regulated by TNF-alpha. Furthermore, increased lymphocyte migration into draining lymph nodes of cd73(-/-) mice is largely normalized by pretreatment with the selective A(2B) receptor agonist BAY 60-6583. Adenosine receptor signaling to restrict lymphocyte migration across HEV may be an important mechanism to control the magnitude of an inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424752      PMCID: PMC2709497          DOI: 10.4049/jimmunol.180.9.6288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Microvascular changes in lymph nodes draining skin allografts.

Authors:  N D Anderson; A O Anderson; R G Wyllie
Journal:  Am J Pathol       Date:  1975-10       Impact factor: 4.307

Review 2.  Ligands for L-selectin: homing, inflammation, and beyond.

Authors:  Steven D Rosen
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

3.  Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes.

Authors:  U Dianzani; V Redoglia; M Bragardo; C Attisano; A Bianchi; D Di Franco; U Ramenghi; H Wolff; L F Thompson; A Pileri
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

4.  5'-Nucleotidase is involved in chick embryo myoblast spreading on laminin.

Authors:  B Mehul; M A Doyennette-Moyne; M Aubery; H G Mannherz; P Codogno
Journal:  Cell Biol Int Rep       Date:  1990-02

5.  Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).

Authors:  L F Thomson; J M Ruedi; A Glass; G Moldenhauer; P Moller; M G Low; M R Klemens; M Massaia; A H Lucas
Journal:  Tissue Antigens       Date:  1990-01

6.  Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.

Authors:  Hironori Tsujimoto; Takefumi Uchida; Philip A Efron; Philip O Scumpia; Amrisha Verma; Tadashi Matsumoto; Sven K Tschoeke; Ricardo F Ungaro; Satoshi Ono; Shuhji Seki; Michael J Clare-Salzler; Henry V Baker; Hidetaka Mochizuki; Reuben Ramphal; Lyle L Moldawer
Journal:  J Leukoc Biol       Date:  2005-07-20       Impact factor: 4.962

7.  Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing.

Authors:  A Hamann; D Jablonski-Westrich; A Duijvestijn; E C Butcher; H Baisch; R Harder; H G Thiele
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

8.  Activation of CD44 induces ICAM-1/LFA-1-independent, Ca2+, Mg(2+)-independent adhesion pathway in lymphocyte-endothelial cell interaction.

Authors:  N Toyama-Sorimachi; K Miyake; M Miyasaka
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

9.  Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.

Authors:  M Massaia; L Perrin; A Bianchi; J Ruedi; C Attisano; D Altieri; G T Rijkers; L F Thompson
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

10.  Blood microcirculation in the lymph node during the primary immune response.

Authors:  P G Herman; I Yamamoto; H Z Mellins
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

View more
  35 in total

1.  Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease.

Authors:  Hiroki Tsukamoto; Petya Chernogorova; Korcan Ayata; Ulrike V Gerlach; Ankur Rughani; Jerry W Ritchey; Jayanthi Ganesan; Marie Follo; Robert Zeiser; Linda F Thompson; Marco Idzko
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

Review 2.  Regulation of lymphocyte function by adenosine.

Authors:  Joel Linden; Caglar Cekic
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-05       Impact factor: 8.311

3.  Multiple steps determine CD73 shedding from RPE: lipid raft localization, ARA1 interaction, and MMP-9 up-regulation.

Authors:  Wei Zhang; Shumin Zhou; Guoping Liu; Fanqiang Kong; Song Chen; Hua Yan
Journal:  Purinergic Signal       Date:  2018-11-03       Impact factor: 3.765

4.  TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.

Authors:  Ningwen Tai; F Susan Wong; Li Wen
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

5.  Editorial: CD73 deficiency and immune dysregulation in HIV infection: cause or effect?

Authors:  Linda F Thompson
Journal:  J Leukoc Biol       Date:  2013-10       Impact factor: 4.962

6.  CD73-generated adenosine promotes osteoblast differentiation.

Authors:  Masahide Takedachi; Hiroyuki Oohara; Brenda J Smith; Mitsuyoshi Iyama; Mariko Kobashi; Kenichiro Maeda; Courtney L Long; Mary B Humphrey; Barbara J Stoecker; Satoru Toyosawa; Linda F Thompson; Shinya Murakami
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

7.  CD73 represses pro-inflammatory responses in human endothelial cells.

Authors:  Jana Kg Grünewald; Anne J Ridley
Journal:  J Inflamm (Lond)       Date:  2010-02-05       Impact factor: 4.981

Review 8.  Ectoenzymes in leukocyte migration and their therapeutic potential.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

9.  Laminins affect T cell trafficking and allograft fate.

Authors:  Kristi J Warren; Daiki Iwami; Donald G Harris; Jonathan S Bromberg; Bryna E Burrell
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

10.  Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Authors:  John Stagg; Upulie Divisekera; Nicole McLaughlin; Janelle Sharkey; Sandra Pommey; Delphine Denoyer; Karen M Dwyer; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.